Maine added 10,968 COVID-19 cases to it's official count Feb. 15 as it works through a large backlog of tests, the Portland Press Herald reported.
Public Health
Chasing the latest circulating COVID-19 variant with a targeted vaccine isn't a viable pandemic strategy, experts say, instead calling for an Operation Warp Speed approach for the development of a universal vaccine, The Washington Post reported Feb. 15.
People who receive a COVID-19 booster that's a different brand than their primary vaccine series may be better protected against COVID-19, according to a study from Singapore published Feb. 11 in the Journal of the American Medical Association.
The U.S. could reduce COVID-19 deaths by focusing on one public health strategy that's been largely untapped: encouraging boosters among older adults, The Atlantic reported Feb. 14.
As COVID-19 cases fall and hospitals tiptoe out from yet another surge, the nation is left collectively asking one major question: What comes next?
Advertisement
The effectiveness of mRNA COVID-19 boosters drops after about four months, though they still offer significant protection against hospitalization, according to a CDC study conducted during the omicron surge.
U.S. COVID-19 deaths may remain stable through the end of February, hitting up to 978,000 total deaths, according to ensemble forecasts the CDC published Feb. 7.
Early research from the U.K. offers new insights into the omicron subvariant's spread relative to the original strain.
The nation's seven-day average of new COVID-19 cases, hospitalizations and deaths all fell this week, according to the CDC's COVID data tracker weekly review published Feb. 11.
Sporadic flu activity continues across the U.S., with four states reporting moderate levels, according to the CDC's FluView report published Feb. 11.